{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-038787","form_type":"8-K","ticker":"AZTA","cik":"0000933974","company_name":"Azenta, Inc.","filed_at":"2025-12-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.666098+00:00","generated_at":"2026-05-16T12:12:58.995642+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Azenta sells B Medical Systems to related-party Thelema for $63M; close by Mar 31, 2026","bullets":["Sale of B Medical Systems subsidiary to Thelema S.À R.L. for USD 63M; Thelema is majority-owned by Azenta VP & B Medical CEO Luc Provost.","Thelema deposited $9M; remaining $54M due on or before Mar 31, 2026, subject to securing final residual financing.","If financing condition not satisfied by Mar 31, 2026, Azenta retains $5M break-up fee and may terminate.","Proceeds to be deployed to strengthen company and drive long-term shareholder value, per CEO John Marotta."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-038787","json":"https://secwatch.observer/filing/0001437749-25-038787.json","markdown":"https://secwatch.observer/filing/0001437749-25-038787.md","text":"https://secwatch.observer/filing/0001437749-25-038787.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/933974/000143774925038787/0001437749-25-038787-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/933974/000143774925038787/azta20251226_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T12:12:58.995642+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b4d6beac0627f49b7dfc313965e84f7bcb9de92a","claim":"Azenta, Inc. entered into Share Purchase Agreement with Thelema S.À R.L. valued at USD 63,000,000 (effective 2025-12-23).","evidence_excerpt":"On December 23, 2025, Azenta Germany GmbH, a wholly owned subsidiary of Azenta, Inc. (“Azenta” or the “Company”) entered into a definitive Sale and Purchase Agreement (“Share Purchase Agreement”) with Thelema S.À R.L. (“Thelema”) relating to the entire issued share capital of B Medical Systems S.À R.L. (“B Medical”), a subsidiary of Azenta Germany GmbH.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/933974/000143774925038787/0001437749-25-038787-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"asset purchase"},{"label":"Counterparty","value":"Thelema S.À R.L."},{"label":"Value","value":"USD 63,000,000"},{"label":"Effective","value":"2025-12-23"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}